Cite

HARVARD Citation

    Guidi, L. et al. (n.d.). OC.12.5 VEDOLIZUMAB TROUGH LEVELS AND CLINICAL OUTCOMES IN INFLAMMATORY BOWEL DISEASE. Digestive and liver disease. 50 (2), pp. e99-e100. [Online]. 
  
Back to record